Cargando…
Should Severity Assessments in Healthcare Priority Setting be Risk- and Time-Sensitive?
Background: Severity plays an essential role in healthcare priority setting. Still, severity is an under-theorised concept. One controversy concerns whether severity should be risk- and/or time-sensitive. The aim of this article is to provide a normative analysis of this question. Methods: A reflect...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693510/ https://www.ncbi.nlm.nih.gov/pubmed/37526761 http://dx.doi.org/10.1007/s10728-023-00460-0 |
_version_ | 1785153177014763520 |
---|---|
author | Sandman, Lars Liliemark, Jan |
author_facet | Sandman, Lars Liliemark, Jan |
author_sort | Sandman, Lars |
collection | PubMed |
description | Background: Severity plays an essential role in healthcare priority setting. Still, severity is an under-theorised concept. One controversy concerns whether severity should be risk- and/or time-sensitive. The aim of this article is to provide a normative analysis of this question. Methods: A reflective equilibrium approach is used, where judgements and arguments concerning severity in preventive situations are related to overall normative judgements and background theories in priority-setting, aiming for consistency. Analysis, discussion, and conclusions: There is an argument for taking the risk of developing a condition into account, and we do this when we consider the risk of dying in the severity assessment. If severity is discounted according to risk, this will ‘dilute’ severity, depending on how well we are able to delineate the population, which is dependent on the current level of knowledge. This will potentially have a more far-reaching effect when considering primary prevention, potentially the de-prioritisation of effective preventive treatments in relation to acute, less-effective treatments. The risk arguments are dependent on which population is being assessed. If we focus on the whole population at risk, with T(0) as the relevant population, this supports the risk argument. If we instead focus on the population of as-yet (at T(0)) unidentified individuals who will develop the condition at T(1), risk will become irrelevant, and severity will not be risk sensitive. The strongest argument for time-sensitive severity (or for discounting future severity) is the future development of technology. On a short timescale, this will differ between different diagnoses, supporting individualised discounting. On a large timescale, a more general discounting might be acceptable. However, we need to also consider the systemic effects of allowing severity to be risk- and time-sensitive. |
format | Online Article Text |
id | pubmed-10693510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-106935102023-12-04 Should Severity Assessments in Healthcare Priority Setting be Risk- and Time-Sensitive? Sandman, Lars Liliemark, Jan Health Care Anal Original Article Background: Severity plays an essential role in healthcare priority setting. Still, severity is an under-theorised concept. One controversy concerns whether severity should be risk- and/or time-sensitive. The aim of this article is to provide a normative analysis of this question. Methods: A reflective equilibrium approach is used, where judgements and arguments concerning severity in preventive situations are related to overall normative judgements and background theories in priority-setting, aiming for consistency. Analysis, discussion, and conclusions: There is an argument for taking the risk of developing a condition into account, and we do this when we consider the risk of dying in the severity assessment. If severity is discounted according to risk, this will ‘dilute’ severity, depending on how well we are able to delineate the population, which is dependent on the current level of knowledge. This will potentially have a more far-reaching effect when considering primary prevention, potentially the de-prioritisation of effective preventive treatments in relation to acute, less-effective treatments. The risk arguments are dependent on which population is being assessed. If we focus on the whole population at risk, with T(0) as the relevant population, this supports the risk argument. If we instead focus on the population of as-yet (at T(0)) unidentified individuals who will develop the condition at T(1), risk will become irrelevant, and severity will not be risk sensitive. The strongest argument for time-sensitive severity (or for discounting future severity) is the future development of technology. On a short timescale, this will differ between different diagnoses, supporting individualised discounting. On a large timescale, a more general discounting might be acceptable. However, we need to also consider the systemic effects of allowing severity to be risk- and time-sensitive. Springer US 2023-08-01 2023 /pmc/articles/PMC10693510/ /pubmed/37526761 http://dx.doi.org/10.1007/s10728-023-00460-0 Text en © The Author(s) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Sandman, Lars Liliemark, Jan Should Severity Assessments in Healthcare Priority Setting be Risk- and Time-Sensitive? |
title | Should Severity Assessments in Healthcare Priority Setting be Risk- and Time-Sensitive? |
title_full | Should Severity Assessments in Healthcare Priority Setting be Risk- and Time-Sensitive? |
title_fullStr | Should Severity Assessments in Healthcare Priority Setting be Risk- and Time-Sensitive? |
title_full_unstemmed | Should Severity Assessments in Healthcare Priority Setting be Risk- and Time-Sensitive? |
title_short | Should Severity Assessments in Healthcare Priority Setting be Risk- and Time-Sensitive? |
title_sort | should severity assessments in healthcare priority setting be risk- and time-sensitive? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693510/ https://www.ncbi.nlm.nih.gov/pubmed/37526761 http://dx.doi.org/10.1007/s10728-023-00460-0 |
work_keys_str_mv | AT sandmanlars shouldseverityassessmentsinhealthcareprioritysettingberiskandtimesensitive AT liliemarkjan shouldseverityassessmentsinhealthcareprioritysettingberiskandtimesensitive |